SCHEMBL8437426

SCHEMBL8437426

COc1cc(CC(=O)N2CCc3cc(CN(C)C)oc3C2)ccc1OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.52
NPC1 O15118 3/20 0.52
MEN1 O00255 4/20 0.47
GPR183 P32249 1/20 0.44
PTGDR2 Q9Y5Y4 2/20 0.44
KDM4E B2RXH2 3/20 0.43
RAB9A P51151 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
BLM P54132 1/20 0.43
APP P05067 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 1/20 0.43
ABCB1 P08183 1/20 0.43
ABCC1 P33527 1/20 0.43
CHRNA7 P36544 2/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8440804 0.99 KMT2A (0.52) KMT2ANPC1MEN1GPR183PTGDR2
SCHEMBL8437814 0.93 KMT2A (0.52) KMT2ANPC1MEN1GPR183PTGDR2
Hydrochloric Acid SCHEMBL8434968 0.93 KMT2A (0.52) KMT2ANPC1MEN1GPR183PTGDR2
SCHEMBL8436351 0.83 KMT2A (0.58) KMT2ANPC1MEN1GPR183PTGDR2
SCHEMBL9416631 0.81 KMT2A (0.76) KMT2ANPC1MEN1GPR183KDM4E
SCHEMBL8439752 0.79 KMT2A (0.58) KMT2ANPC1MEN1GPR183PTGDR2
SCHEMBL8434347 0.77 FFAR1 (0.48) KMT2ANPC1MEN1RAB9ACYP1A2
SCHEMBL8437838 0.77 FFAR1 (0.48) KMT2ANPC1MEN1RAB9ACYP1A2
SCHEMBL8805903 0.77 CHRNA7 (0.41) KMT2ANPC1MEN1KDM4ERAB9A
Hydrochloric Acid SCHEMBL8435262 0.77 FFAR1 (0.47) KMT2ANPC1MEN1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998433-A THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-07 US disclosed
CN-1160403-A Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-24 CN disclosed
EP-0785939-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 1997-07-30 EP disclosed
WO-1996011201-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-18 WO disclosed